bisoprolol fumarate

Also found in: Dictionary.
Related to bisoprolol fumarate: Beta blockers

bisoprolol fumarate

Apo-Bisoprolol, Bisoprolol (CA), Cardicor (UK), Emcor (UK), Emcor LS (UK), Monocor (CA), Novo-Bisoprolol (CA), PMS-Bisoprolol (CA), Sandoz Bisoprolol (CA), Zebeta

Pharmacologic class: Beta1-adrenergic blocker

Therapeutic class: Antihypertensive

Pregnancy risk category C


Blocks beta1-adrenergic receptors of sympathetic nervous system in heart and kidney, thereby decreasing myocardial excitability, myocardial oxygen consumption, cardiac output, and renin release from kidney. Also lowers blood pressure without affecting beta2-adrenergic (pulmonary, vascular, and uterine) receptor sites.


Tablets: 5 mg, 10 mg

Indications and dosages


Adults: Initially, 2.5 to 5 mg P.O. daily. Dosages up to 20 mg P.O. daily have been used.

Dosage adjustment

• Renal or hepatic impairment


• Hypersensitivity to drug
• Sinus bradycardia
• Second- or third-degree heart block
• Cardiogenic shock
• Heart failure
• Children (safety and efficacy not established)


Use cautiously in:
• renal or hepatic impairment, pulmonary disease, asthma, diabetes mellitus, thyrotoxicosis, peripheral vascular disease
• patients undergoing anesthesia or major surgery
• elderly patients
• pregnant or breastfeeding patients.


• Give with or without food, but be consistent to minimize variations in absorption.
• Be aware that drug may be given alone or added to diuretic therapy.

Adverse reactions

CNS: dizziness, depression, paresthesia, sleep disturbances, hallucinations, memory loss, slurred speech

CV: bradycardia, peripheral vascular insufficiency, claudication, hypotension, sinoatrial or atrioventricular (AV) node block, second- or third-degree heart block, heart failure, pulmonary edema, cerebrovascular accident, arrhythmias

EENT: blurred vision, dry eyes, conjunctivitis, tinnitus, rhinitis, pharyngitis

GI: nausea, vomiting, diarrhea, constipation, gastric pain, gastritis, flatulence, anorexia, ischemic colitis, acute pancreatitis, renal and mesenteric arterial thrombosis

GU: dysuria, polyuria, nocturia, erectile dysfunction, Peyronie's disease, decreased libido

Hematologic: eosinophilia, agranulocytosis, thrombocytopenia

Hepatic: hepatomegaly

Metabolic: hyperglycemia, hypoglycemia

Musculoskeletal: arthralgia, muscle cramps

Respiratory: dyspnea, cough, bronchial obstruction, bronchospasm

Skin: rash, purpura, pruritus, dry skin, excessive sweating


Drug-drug.Amphetamines, ephedrine, epinephrine, norepinephrine, phenylephrine, pseudoephedrine: unopposed alpha-adrenergic stimulation

Antihypertensives: increased hypotension

Digoxin: additive bradycardia

Dobutamine, dopamine: decrease in beneficial beta1-adrenergic cardiovascular effects

General anesthetics, I.V. phenytoin, verapamil: additive myocardial depression

MAO inhibitors: hypertension (when taken within 14 days of bisoprolol)

Nonsteroidal anti-inflammatory drugs: decreased antihypertensive effect

Thyroid preparations: decreased bisoprolol efficacy

Drug-diagnostic tests.Alanine aminotransferase, alkaline phosphatase, aspartate aminotransferase, blood urea nitrogen, glucose, low-density lipoproteins,

potassium, uric acid: increased levels

Antinuclear antibodies: increased titers

Insulin tolerance test: test interference

Drug-behaviors.Acute alcohol ingestion: additive hypotension

Cocaine use: unopposed alpha-adrenergic stimulation

Patient monitoring

• Closely monitor blood glucose levels in diabetic patients.
• Assess for signs and symptoms of heart failure, including weight gain.
• Stay alert for blood pressure variations. Low blood pressure may indicate overdose.

Patient teaching

• Tell patient to weigh himself daily at same time and to report gain of 3 to 4 lb/day.
• Instruct patient to move slowly when sitting up or standing, to avoid dizziness or light-headedness from blood pressure decrease.
• Caution patient to avoid driving and other hazardous activities until he knows how drug affects concentration and alertness.
• Advise patient to restrict salt intake to help avoid fluid retention.
• Caution patient not to discontinue drug abruptly unless prescriber approves.
• Tell patient to carry medical identification stating that he's taking a beta blocker.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, and behaviors mentioned above.

bisoprolol fumarate (bis´ōprō´lol fyōō´mərāt´),

n brand name: Zebeta;
drug class: antihypertensive, selective β1 blocker;
action: produces fall in blood pressure without reflex tachycardia or significant reduction in heart rate;
uses: treatment of hypertension as a single agent or in combination.
Mentioned in ?
References in periodicals archive ?
Bisoprolol fumarate, permeation enhancer, polysorbate 80, rabbit's skin, transdermal patch.
Bisoprolol fumarate (donated by Mass Pharma, Lahore, Pakistan), Eudragit RS100 (Merck, Germany), Hydroxypropyl methylcellulose E5 (Merck, Germany), Polyethylene glycol 400 (Merck, Germany), Polysorbate 80 (Daejung, Korea), Polyvinyl alcohol (Merck, Germany), Sodium chloride (Merck, Germany), Potassium chloride (Aldrich Chemical Co Ltd.
Formulation of optimized transdermal patch of Bisoprolol fumarate using polysorbate 80 as permeation enhancer.
In vitro skin permeation studies such as percentage drug release, flux, permeability coefficient and enhancement ratio (ER) for Bisoprolol fumarate across rabbit skin were estimated.
Weight variation, thickness, drug content, swelling index and percentage weight increased due to swelling results of matrix type transdermal patch of Bisoprolol fumarate.
Moisture content, percentage moisture uptake at 84% RH, water vapor transmission rate and water vapor permeability results of matrix type transdermal patch of Bisoprolol fumarate.
Flux, permeability coefficient and enhancement ratio (ER) of bisoprolol fumarate matrix patch containing permeation enhancers.
The introduction of Bisoprolol Fumarate, our third exclusive generic thus far this year, is part of Eon's strategy to be first to market with niche, as well as blockbuster generics", said Frank Della Fera, Vice President of Sales and Marketing for Eon Labs.
For more information on Eon Bisoprolol Fumarate, or other quality products from Eon Labs, call 1-800-526-0225, or write to Eon Labs Manufacturing, Inc.
Investors are cautioned that forward-looking statements involve risks and uncertainties which may affect the company's business and prospects, including the risk that Zenith Goldline Pharmaceuticals will not launch bisoprolol fumarate and hydrochlorothiazide tablets or that its launch will be delayed, and certain other risks and uncertainties based on economic, competitive, governmental, technological and other factors discussed in the Company's 1999 annual report on form 10-KA and its other filings with the Securities and Exchange Commission.
Bisoprolol Fumarate and Hydrochlorothiazide is the generic equivalent to Lederle Laboratories Ziac(R) Tablets, which are indicated for the management of hypertension.